NDC 61825-303

Oravig

Miconazole

Oravig is a Buccal Tablet in the Human Prescription Drug category. It is labeled and distributed by Galt Pharmaceuticals, Llc. The primary component is Miconazole.

Product ID61825-303_d4807a52-d3f1-07cc-e053-2995a90a53e0
NDC61825-303
Product TypeHuman Prescription Drug
Proprietary NameOravig
Generic NameMiconazole
Dosage FormTablet
Route of AdministrationBUCCAL
Marketing Start Date2021-12-31
Marketing CategoryNDA /
Application NumberNDA022404
Labeler NameGalt Pharmaceuticals, LLC
Substance NameMICONAZOLE
Active Ingredient Strength50 mg/1
Pharm ClassesAzole Antifungal [EPC],Azoles [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 61825-303-14

14 TABLET in 1 BOTTLE (61825-303-14)
Marketing Start Date2021-12-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Oravig" or generic name "Miconazole"

NDCBrand NameGeneric Name
61825-303OravigMiconazole
89141-250ORAVIGmiconazole
67777-316Dynarex Antifungal PowderMiconazole
69020-208MakeSenseMiconazole
61715-050MICONAZOLEMICONAZOLE
42669-073Miconazole Foot PowderMiconazole
15071-804Rash Relief AntifungalMiconazole

Trademark Results [Oravig]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ORAVIG
ORAVIG
88094144 not registered Live/Pending
Midatech Pharma US Inc.
2018-08-27
ORAVIG
ORAVIG
85188886 3966483 Dead/Cancelled
DARA BIOSCIENCES, INC.
2010-12-02
ORAVIG
ORAVIG
77627417 not registered Dead/Abandoned
Par Pharmaceutical Companies, Inc
2008-12-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.